Related Experiment Videos
Ophthalmic features of giant cell arteritis
Bailliere'S Clinical Rheumatology
|December 1, 1991
Summary
Giant cell arteritis (GCA) is a critical eye emergency. Prompt diagnosis and aggressive treatment of GCA can prevent vision loss, making early intervention crucial for preserving sight.
Area of Science:
- Ophthalmology
- Rheumatology
- Vascular Medicine
Background:
- Giant cell arteritis (GCA) presents a significant risk of irreversible blindness.
- Ocular complications of GCA are primarily ischemic, with anterior ischemic optic neuropathy (AION) being the most common cause of vision loss.
Purpose of the Study:
- To emphasize the ophthalmic emergency status of GCA.
- To detail the diagnosis of arteritic AION.
- To discuss the management of GCA concerning visual loss.
Main Methods:
- Review of clinical manifestations of GCA affecting the eye.
- Discussion on diagnostic criteria for arteritic AION.
- Analysis of treatment strategies for visual preservation in GCA.
Main Results:
- Untreated GCA carries a high risk of permanent, painless blindness.
- Early and aggressive treatment of GCA can almost entirely prevent vision loss.
- Common causes of blindness include AION, with rarer instances of central retinal or cilioretinal artery occlusion.
Conclusions:
- GCA is a treatable cause of blindness if identified and managed promptly.
- Urgent and aggressive treatment is paramount to prevent visual morbidity.
- Understanding the ischemic nature of GCA's ocular manifestations is key to timely diagnosis and effective management.